We present one of the first comprehensive evaluations of predictive information derived from retinal fundus photographs, illustrating the potential and limitations of readily accessible and low-cost ...

In its complete response letter, the FDA said Aldeyra had failed to demonstrate reproxalap’s efficacy in adequate and ...

The FDA has, for a third time, declined to approve reproxalap for the treatment of dry eye disease, according to a press ...

Women over 50 face increased eye health risks post-menopause due to hormonal shifts. Conditions like dry eye, cataracts, glaucoma, and age-related macular degeneration become more prevalent.

Researchers have found in a new study that advanced periodontal inflammation (stage III–IV) may cause degenerative changes in retinal microvasculature and neural tissues. The increasing severity ...

After delaying its review, the FDA has rejected Aldeyra Therapeutics’ experimental dry eye disease treatment for the third time. | After delaying its review, the FDA has rejected Aldeyra Therapeutics’ ...

Prevent Blindness, the nation's leading patient advocacy organization dedicated to preventing blindness and preserving sight, has declared March 23-29, 2026, as its first-ever Keratoconus Week. The ...

Scientists found that protein deposits in the retina create unique light patterns for different brain diseases in humans.

A common medication may have an unexpected effect on a serious eye condition, new research suggests.

With the singular exception of punctal or canalicular occlusion, when we are talking about in-office dry eye disease ...

Researchers develop a 96% accurate AI-powered retinal scan to distinguish between Alzheimer’s and ALS by detecting specific protein deposits.

Metformin use in people with diabetes was linked to a significantly lower risk of developing intermediate age-related macular degeneration.